Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Dow
Boehringer Ingelheim
Daiichi Sankyo
Julphar
McKinsey
Moodys
Healthtrust
Harvard Business School

Generated: February 18, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RITALIN LA

« Back to Dashboard

Clinical Trials for Ritalin La

Trial ID Title Status Sponsor Phase Summary
NCT00018863 Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) Unknown status National Institute of Mental Health (NIMH) Phase 3 This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).
NCT00018863 Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) Unknown status New York State Psychiatric Institute Phase 3 This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).
NCT00025779 Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders Completed National Institute of Mental Health (NIMH) N/A This study will evaluate the efficacy and safety of methylphenidate for treating hyperactivity, impulsiveness, and distractibility in 60 children and adolescents with Pervasive Developmental Disorders (PDD). Methylphenidate (Ritalin)is approved by the Food and Drug Administration for the treatment of children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD). Data supporting its safety and effectiveness in treating ADHD symptoms in PDD are limited. Children and adolescents who do not show a positive response to methylphenidate will be invited to participate in a pilot study of the non-stimulant medication guanfacine (Tenex).
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ritalin La

Condition Name

Condition Name for Ritalin La
Intervention Trials
Attention Deficit Hyperactivity Disorder 20
Healthy 9
Attention Deficit Disorder With Hyperactivity 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ritalin La
Intervention Trials
Attention Deficit Disorder with Hyperactivity 37
Hyperkinesis 28
Disease 21
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ritalin La

Trials by Country

Trials by Country for Ritalin La
Location Trials
United States 91
Israel 16
Canada 9
Netherlands 4
Switzerland 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ritalin La
Location Trials
California 12
Texas 9
Massachusetts 8
Ohio 7
New York 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ritalin La

Clinical Trial Phase

Clinical Trial Phase for Ritalin La
Clinical Trial Phase Trials
Phase 4 27
Phase 3 14
Phase 2/Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ritalin La
Clinical Trial Phase Trials
Completed 46
Recruiting 18
Unknown status 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ritalin La

Sponsor Name

Sponsor Name for Ritalin La
Sponsor Trials
Massachusetts General Hospital 7
National Institute of Mental Health (NIMH) 7
M.D. Anderson Cancer Center 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ritalin La
Sponsor Trials
Other 125
NIH 19
Industry 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
Chubb
Mallinckrodt
Queensland Health
Express Scripts
Deloitte
Johnson and Johnson
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.